ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • socioeconomic status and rheumatoid arthritis (RA)
  • socioeconomic status and systemic lupus erythematosus (SLE)
  • socioeconomic status and systemic sclerosis
  • Sodium Urate Crystals
  • Sodium Urate Crystals and imaging techniques
  • sonography
  • sonography and systemic sclerosis
  • sonography and ultrasound
  • Southend pre-test probability score
  • spaced education
  • Specialty
  • Specialty Pharmacy
  • sphingosine-1-phosphate receptor and S1P1
  • spine
  • spine involvement
  • spine involvement and back surgery
  • spine involvement and spondylarthritis
  • spine involvement and spondylarthropathy
  • Spine involvement and systemic lupus erythematosus (SLE)
  • spine involvement and thyroid
  • spine involvement and ultrasound
  • spliceosome
  • Spondylarthritis
  • spondylarthritis and ankylosing spondylitis (AS)
  • spondylarthritis and fibromyalgia
  • spondylarthritis and Imaging
  • spondylarthritis and spondylarthropathy
  • spondylarthritis and statistical methods
  • spondylarthritis and strategic planning
  • spondylarthritis and stress
  • spondylarthritis and synovial cells
  • spondylarthritis and synovial fluid
  • spondylarthritis and synovitis
  • spondylarthritis and technology
  • spondylarthritis and therapy
  • spondylarthritis and tissue remodeling
  • spondylarthritis and tobacco use
  • spondylarthritis and tofacitinib
  • spondylarthritis and toll-like receptors
  • spondylarthritis and transcription factor
  • spondylarthritis and transcriptional regulation
  • spondylarthritis and treatment
  • spondylarthritis and treatment guidlelines
  • spondylarthritis and treatment options
  • spondylarthritis and tuberculosis
  • Spondylarthritis and tumor necrosis factor (TNF)
  • spondylarthritis and ultrasonography
  • spondylarthritis and ultrasound
  • spondylarthritis and uveitis
  • spondylarthritis and vaccines
  • spondylarthritis and work
  • spondylarthritis and x-ray
  • spondylarthritis and year in review
  • Spondylarthropathies
  • Spondylarthropathy
  • spondylarthropathy and psoriatic arthritis
  • spondylarthropathy and subchondral bone
  • spondylarthropathy and surgery
  • spondylarthropathy and therapy
  • Spondylarthropathy and thrombosis
  • spondylarthropathy and total joint replacement
  • spondylarthropathy and treatment
  • spondylarthropathy and treatment options
  • spondylarthropathy and tuberculosis
  • spondylarthropathy and tumor necrosis factor (TNF)
  • spondylarthropathy and ultrasound
  • Spondylarthropathy and uveitis
  • spondylarthropathy and vaccines
  • spondylarthropathy and x-ray
  • spondyloarthritis
  • spondyloarthritis and rheumatologists
  • Spondyloarthropathies
  • spontaneous abortion and sFlt-1
  • SS-RNA-Seq
  • ssc
  • Standardized Incidence Ratio
  • states of activation and tocilizumab
  • statin
  • Statin-induced myopathies
  • statin-induced myopathies and treatment
  • statins
  • statins and cardiovascular disease
  • statins and clinical trials
  • statins and seasons
  • statins and systemic lupus erythematosus (SLE)
  • statins and temporal arteritis
  • statins and thrombosis
  • statins and tumor necrosis factor (TNF)
  • statins and vasculitis
  • Statistical methods
  • statistical methods and Musculoskeletal
  • statistical methods and statistics
  • statistical methods and systemic sclerosis
  • statistical methods and transcriptional regulation
  • statistical methods and ultrasound
  • statistical methods and vasculitis
  • statistics and statistical methods
  • statistics and steroids
  • statistics and systemic sclerosis
  • stem cell transplantaiton
  • Stem cells
  • stem cells and synovitis
  • stem cells and systemic sclerosis
  • stem cells and therapy
  • stem cells and transcription factor
  • stem cells and treatment options
  • Stereotype
  • steroids
  • steroids and remission
  • steroids and synovitis
  • steroids and systemic lupus erythematosus (SLE)
  • steroids and temporal arteritis
  • steroids and tendonitis/bursitis
  • Steroids and thrombocytopenia
  • steroids and thyroid
  • Steroids and tocilizumab
  • steroids and tofacitinib
  • steroids and treatment
  • steroids and tumor necrosis factor (TNF)
  • steroids and ultrasonography
  • steroids and ultrasound
  • steroids and vasculitis
  • steroids and viruses
  • stigma
  • Still's disease
  • Still's disease and malignancy
  • Still's disease and prognostic factors
  • Still's disease and tocilizumab
  • strength and systemic sclerosis
  • strength and treatment
  • stress
  • stress and joint arthroplasty
  • stress and practice improvement
  • stress and SLE and adverse childhood experiences
  • stress and systemic lupus erythematosus (SLE)
  • stress and tai chi
  • stress and vasculitis
  • Stretching
  • Stroke
  • stroke and autoantibodies
  • Stromal Cells
  • Stromal cells and SSc
  • Structure
  • Study Design
  • subchondral bone and therapy
  • Subclinical Cardiovascular Disease
  • subclinical disease
  • sun
  • support
  • Support and Education Groups
  • Support and Education Groups and coping
  • Support and Education Groups and education
  • Support and Education Groups and pediatric rheumatology
  • support and technology
  • suppressive function
  • surgery
  • surgery and synovial fluid
  • surgery and synovium
  • surgery and systemic lupus erythematosus (SLE)
  • surgery and takayasu arteritis
  • surgery and tobacco use
  • surgery and tocilizumab
  • surgery and vasculitis
  • surgery and weight loss
  • surgery and young adults
  • surgical management
  • survey
  • survey and Rheumatology
  • survey and tapering
  • Surveys
  • survival
  • survival analysis
  • survival and relapse
  • survivin
  • survivor
  • sustainable
  • sustained remission and functional status
  • swelling
  • switched memory B-cells
  • switching
  • SYK
  • SYK and rheumatoid arthritis
  • SYK and rheumatoid arthritis (RA)
  • SYK and T cells
  • syk and tissue remodeling
  • Symptom Trajectories
  • symptoms
  • Synovectomy
  • synovectomy and synovitis
  • synovial
  • synovial biopsy
  • synovial cells
  • synovial cells, synovial fluid
  • synovial fluid
  • synovial fluid and monoclonal antibodies
  • synovial fluid and synovitis
  • synovial fluid and synovium
  • synovial fluid and therapeutic targeting
  • synovial fluid and thyroid
  • synovial fluid and tocilizumab
  • First |
  • « Previous Page
  • 56
  • 57
  • 58
  • 59
  • 60
  • [61]
  • 62
  • 63
  • 64
  • 65
  • 66
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology